Comparison of Classical P81 and SVI-P Cation-Exchange Papers in Radiometric Protein Kinase Assays

  • Biochem J. 2025 Jul 22:BCJ20240731. doi: 10.1042/BCJ20240731.
Muhammad Khabib  #  1  2 Lifang Zhang  #  1 Ashley Ovens  2 Abdulhameed Al-Ghabkari  3 John Scott  4  5 Lindsay Sparrow  1 Martha Blank  6 Lisa Murray-Segal  1 Sandra Galic  1  7 Morag Park  3  8  9  10 Christopher Langendorf  2  7 Naomi Ling  1 Ashfaqul Hoque  1  7
Affiliations
  • 1. Metabolic Signalling Laboratory, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia, CA.
  • 2. Protein Engineering in Immunity and Metabolism Unit, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia, AU.
  • 3. McGill University Rosalind and Morris Goodman Cancer Research Centre, Montreal, Québec, Canada, AU.
  • 4. Monash Institute of Pharmaceutical Sciences Drug Discovery Biology, Parkville, Victoria, Australia, AU.
  • 5. The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia, CA.
  • 6. St Vincent's Institute of Medical Research Bone Cell Biology and Disease Unit, Fitzroy, Victoria, Australia, CA.
  • 7. The University of Melbourne Melbourne Medical School, Melbourne, Victoria, Australia, CA.
  • 8. McGill University Department of Biochemistry, Montreal, Québec, Canada.
  • 9. McGill University Department of Medicine, Montreal, Québec, Canada.
  • 10. McGill University Gerald Bronfman Department of Oncology, Montreal, Québec, Canada.
  • # Contributed equally.
Abstract

Radiometric kinase assays have been widely used due to their high sensitivity and dynamic range. The assay measures the transfer of 32Pi from [γ-32P]-ATP to specific substrates, typically synthetic peptides. The 32P-phosphorylated peptide product is captured by binding it to phosphocellulose paper, specifically P81. Unfortunately, GE Healthcare, the sole supplier of P81, has discontinued its manufacture. Recently, a replacement for P81, SVI-P cation-exchange filter paper, has become available. We have tested SVI-P in various kinase assays, including those for AMPK, Abl, CDK2, and ERK, and found that it performs comparably to P81 in capturing substrates. Additionally, a commercial kinase profiling assay using SVI-P successfully captured a range of peptide and protein substrates from 48 different protein kinases. One minor limitation of SVI-P was the higher background radioactivity; however, this can be addressed through optimisation and extended wash steps. Overall, SVI-P represents a viable alternative for radiometric kinase assays, ensuring continued reliability in both academic and industrial research settings.

Keywords
Biochemical techniques and resources; P81; SVI-P; [γ-32P]-ATP; kinases; radiometric kinase assay.
Products